市場調査レポート

商品コード

1569488

合成生物学の市場規模、シェア、成長分析：ツール別、技術別、用途別、地域別 - 産業予測、2024-2031年

Synthetic Biology Market Size, Share, Growth Analysis, By Tool, By Technology, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年10月13日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

合成生物学の世界市場規模は2022年に113億米ドルとなり、2023年の141億8,000万米ドルから2031年には872億7,000万米ドルに達し、予測期間（2024-2031年）のCAGRで25.5%の成長が予測されています。

合成生物学市場は、技術革新と持続可能な代替品への需要の高まりが主な要因となって、今後数年間で力強い成長を遂げる見通しです。遺伝子編集技術、特にCas9とCRISPRの主要な進歩は、合成遺伝子合成の改善とともに、合成生物学アプリケーションの効率と費用対効果を高めています。これは、環境問題への関心や持続可能性の推進が注目されるにつれて、グリーンケミカル、生分解性材料、バイオ燃料などの持続可能なソリューションへの関心が高まっていることによってさらに促進されています。しかし、遺伝子組み換え、環境への影響、バイオセーフティに関する議論など、倫理的・規制的なハードルに起因する課題に直面しており、これが商業化と現在進行中の研究イニシアチブの両方の妨げになる可能性があります。このような障害にもかかわらず、楽観的な見方は変わっていないです。特に、先進治療や個別化医療の出現は、これまで治療不可能であった病態に対処することで、ヘルスケアに革命をもたらすと期待されています。このように、合成生物学市場は岐路に立たされており、技術的進歩と社会的要求がイノベーションを後押しする一方で、規制の枠組みは倫理的配慮に対処するために進化しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- イタリア
- フランス
- 英国
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

[if!supportLists][endif]Thermo Fisher Scientific, Inc.（US）
Merck KGaA（Germany）
Agilent Technologies（US）
Novozymes（Denmark）
Ginkgo Bioworks（US）
Amyris（US）
Precigen, Inc.（US）
GenScript（China）
Twist Bioscience（US）
Synthetic Genomics（US）
Codexis, Inc.（US）
Synthego（US）
Creative Enzymes（US）
Eurofins Scientific（Luxembourg）
Bota Biosciences Inc.（China）
Creative Biogene（US）
Enbiotix, Inc.（US）
Illumina, Inc.（US）
New England Biolabs（US）
Pareto Bio, Inc.（US）

Product Code: SQMIG35H2209

Global Synthetic Biology Market size was valued at USD 11.3 Billion in 2022 and is poised to grow from USD 14.18 Billion in 2023 to USD 87.27 Billion by 2031, at a CAGR of 25.5% over the forecast period (2024-2031).

The synthetic biology market is poised for robust growth in the coming years, driven largely by technological innovations and an increasing demand for sustainable alternatives. Key advancements in gene editing technologies, particularly Cas9 and CRISPR, along with improvements in synthetic gene synthesis, are enhancing the efficiency and cost-effectiveness of synthetic biology applications. This is further fueled by the rising interest in sustainable solutions, such as green chemicals, biodegradable materials, and biofuels, as environmental concerns and the push for sustainability gain prominence. However, the market faces challenges stemming from ethical and regulatory hurdles, including debates over genetic modifications, environmental impacts, and biosafety, which may hinder both commercialization and ongoing research initiatives. Despite these obstacles, the landscape remains optimistic, particularly with the emergence of advanced therapies and personalized medicine, which hold the promise to revolutionize healthcare by addressing previously untreatable conditions. As such, the synthetic biology market stands at a crossroads, with technological progress and societal demands pushing for innovation, while regulatory frameworks evolve to address ethical considerations.

Top-down and bottom-up approaches were used to estimate and validate the size of the global synthetic biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global synthetic biology Market Segmental Analysis

The Global Synthetic Biology Market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the market is segmented into Medical Application, Pharmaceuticals, Drug Discovery and Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the global synthetic biology Market

The global synthetic biology market is being significantly driven by the advancements in healthcare and agriculture, where innovative therapies, diagnostics, and vaccines are being developed at an unprecedented pace. The ability of synthetic biology to engineer microorganisms and plants has revolutionized the pharmaceutical sector, enabling the rapid production of targeted treatments and improved diagnostics. Simultaneously, in agriculture, genetically tailored crops designed for enhanced resistance against diseases and pests contribute to greater agricultural productivity and food security, addressing critical global challenges. This dual impact on healthcare and agriculture not only sparks market growth but also fosters broader societal benefits, thereby driving further investment and innovation in synthetic biology.

Restraints in the global synthetic biology Market

The high initial costs associated with the development of synthetic biology technologies serve as a significant market restraint for the global synthetic biology market. These financial barriers limit scalability and accessibility, particularly for smaller companies and emerging economies. Additionally, the complexities involved in engineering, designing, and integrating synthetic biological systems pose substantial challenges, potentially undermining the reliability and efficiency of these technologies. As a result, these factors could deter investment and innovation, slowing the overall growth of the market and limiting the effectiveness of synthetic biology solutions in addressing various biotechnological needs.

Market Trends of the global synthetic biology Market

The global synthetic biology market is increasingly trending towards the integration of epigenetic technologies, as new entrants strive to address the complexities of engineered gene expression. The dynamic interplay of epigenetics and DNA sequences often leads to inconsistent outcomes, prompting innovative solutions that enhance the reliability and predictability of synthetic constructs. Startups and established firms alike are leveraging advancements in epigenetic engineering to refine genetic modifications, ensuring better control over gene activity. This focus on epigenetics is expected to drive growth in the sector, as it enables developers to create more sophisticated and effective biotechnological applications across various industries.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Patent Analysis
Pricing Analysis
Regulatory Analysis
Value Chain Analysis
Ecosystem of the Market
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Synthetic Biology Market by Tool

Market Overview
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids

Synthetic Biology Market by Technology

Market Overview
Gene Synthesis
Genome Engineering
Sequencing, Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology

Synthetic Biology Market by Application

Market Overview

Synthetic Biology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- Italy
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

[if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novozymes (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ginkgo Bioworks (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amyris (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Precigen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthetic Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Enzymes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bota Biosciences Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enbiotix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pareto Bio, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

合成生物学の市場規模、シェア、成長分析：ツール別、技術別、用途別、地域別 - 産業予測、2024-2031年

Synthetic Biology Market Size, Share, Growth Analysis, By Tool, By Technology, By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

合成生物学市場：ツール別

合成生物学市場：技術別

合成生物学市場：用途別

合成生物学市場規模：地域別